The scientist’s investigation covers issues in Internal medicine, Meta-analysis, Randomized controlled trial, Kidney disease and Surgery. His work deals with themes such as Diabetes mellitus, Endocrinology, Type 2 diabetes and Lyme disease, which intersect with Internal medicine. The various areas that Christopher H. Schmid examines in his Meta-analysis study include Odds ratio, Relative risk, Clinical trial and Regression.
His Kidney disease research incorporates themes from Creatinine, Angiotensin-converting enzyme and Renal function. His Creatinine research integrates issues from Nephropathy and Urology. His studies deal with areas such as Health statistics, Mesoamerican nephropathy and Geriatric nephrology as well as Cystatin C.
His scientific interests lie mostly in Internal medicine, Meta-analysis, Randomized controlled trial, Surgery and Statistics. Kidney disease is the focus of his Internal medicine research. His study on Kidney disease also encompasses disciplines like
Myocardial infarction is closely connected to Odds ratio in his research, which is encompassed under the umbrella topic of Meta-analysis. His Randomized controlled trial research incorporates elements of Placebo, Physical therapy, Clinical trial and Quality of life. His study in Surgery is interdisciplinary in nature, drawing from both Carcinoma and Risk factor.
Christopher H. Schmid mainly focuses on Meta-analysis, Internal medicine, Randomized controlled trial, N of 1 trial and Statistics. His work in the fields of Meta-analysis, such as Publication bias, overlaps with other areas such as Modalities. Christopher H. Schmid has researched Internal medicine in several fields, including Multiple drug resistance and Antibiotic resistance.
His Randomized controlled trial study combines topics from a wide range of disciplines, such as Physical therapy, Disease severity and Confidence interval. His research integrates issues of Research design, Osteoarthritis and Intention-to-treat analysis in his study of Physical therapy. His N of 1 trial research includes elements of mHealth, Family medicine, Chronic pain, Clinical psychology and Protocol.
Christopher H. Schmid spends much of his time researching N of 1 trial, Randomized controlled trial, Statistics, Systematic review and mHealth. N of 1 trial is a primary field of his research addressed under Internal medicine. His study ties his expertise on Pain Interference together with the subject of Internal medicine.
The concepts of his Randomized controlled trial study are interwoven with issues in Physical therapy and Effect modification, Confidence interval. He studied Statistics and Abstraction that intersect with Generalized linear mixed model and Association. Christopher H. Schmid interconnects Toolbox, Data exchange, Source document and Do Not Track in the investigation of issues within Systematic review.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey;Lesley A. Stevens;Christopher H. Schmid;Yaping (Lucy) Zhang.
Annals of Internal Medicine (2009)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A C Sterne;Alex J Sutton;John P A Ioannidis;Norma Terrin.
BMJ (2011)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton;Georgia Salanti;Deborah M Caldwell;Anna Chaimani.
Annals of Internal Medicine (2015)
Estimating glomerular filtration rate from serum creatinine and cystatin C.
Lesley A. Inker;Christopher H. Schmid;Hocine Tighiouart;John H. Eckfeldt.
The New England Journal of Medicine (2012)
Quantitative Synthesis in Systematic Reviews
Joseph Lau;John P.A. Ioannidis;Christopher H. Schmid.
Annals of Internal Medicine (1997)
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control
Susan L. Norris;Joseph Lau;S. Jay Smith;Christopher H. Schmid.
Diabetes Care (2002)
Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis
Tazeen H. Jafar;Paul C. Stark;Christopher H. Schmid;Marcia Landa.
Annals of Internal Medicine (2003)
The case of the misleading funnel plot.
Joseph Lau;John P A Ioannidis;Norma Terrin;Christopher H Schmid.
BMJ (2006)
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
Lesley A Stevens;Josef Coresh;Christopher H Schmid;Harold I Feldman.
American Journal of Kidney Diseases (2008)
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Susan Y. Chu;William M. Callaghan;Shin Y. Kim;Christopher H. Schmid.
Diabetes Care (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Chinese University of Hong Kong
Tufts Medical Center
Tufts Medical Center
Tufts University
Tufts Medical Center
Stanford University
University of California, Davis
Tufts Medical Center
Northeastern University
University of Sydney
University of Malaya
Nokia (United States)
University of North Carolina at Charlotte
University of Minnesota
Aix-Marseille University
Université Libre de Bruxelles
Oak Ridge National Laboratory
Arizona State University
Eli Lilly (United States)
Broad Institute
University College London
Vrije Universiteit Amsterdam
Royal Belgian Institute for Space Aeronomy
University of Illinois at Urbana-Champaign
Fujita Health University
University of Western Ontario